MAR-COF CG
- Product NDC
- 0682-0475
- 11-digit product format
- 006820475
- Labeler code
- 0682
- Product ID
- 0682-0475_13b802bb-b30a-864a-e063-6394a90a4dfd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CODEINE PHOSPHATE and GUAIFENESIN
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Marnel Pharmaceuticals, LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-12-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 7.5; 225 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 0682-0475-16 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 0682-0475-16 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 0682-0475-16 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 0682-0475-16 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 0682-0475-16 | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MAR-COF CG
- Brand name suffix
- Expectorant
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 7.5 mg/5mL |
| GUAIFENESIN | 225 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60a41229-b125-43d8-b2b4-0bf40feed764 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-03-15 | MAR-COF ® CG Expectorant |
| 2024-01-30 | MAR-COF ® CG Expectorant |
| 2022-10-17 | MAR-COF ® CG Expectorant |
| 2021-07-23 | MAR-COF ® CG Expectorant |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0682-0475-16 | MAR-COF CGExpectorant | 473 mL in 1 BOTTLE | SYRUP | 473 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0682-0475-16 | ML - Milliliter | 0682-0475 | 96e067ee-d836-4dbd-aa6a-1ca12507d95b | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menthol Cough Drops | MENTHOL | Boston Nutraceutical Production SL | 857363b6-e025-e074-e053-2a91aa0a4379 | 2024-10-07 | Warnings | M012 |
| Menthol Cough Drops | MENTHOL | Boston Nutraceutical Production SL | 857365ba-895e-4a63-e053-2991aa0a8b9f | 2024-10-07 | Warnings | M012 |
| Menthol Vapor Cough Drops | MENTHOL | BOSTON NUTRACEUTICAL PRODUCTION, S.L | a7062db1-8201-b400-e053-2a95a90a55e8 | 2024-10-07 | Warnings | M012 |
| Honey Lemon Cough Drops | MENTHOL | Boston Nutraceutical Production SL | b8f48a47-6871-f7ed-e053-2995a90a16f3 | 2024-10-07 | Warnings | M012 |
| Honey Lemon Cough Drops | MENTHOL | Boston Nutraceutical Production SL | 856f0bd8-354b-a002-e053-2a91aa0a8022 | 2024-10-07 | Warnings | M012 |
| Honey Lemon Cough Drops | MENTHOL | Boston Nutraceutical Production SL | 83c4928a-eea6-e176-e053-2991aa0a6bb1 | 2024-10-07 | Warnings | M012 |
| Natural Herbal Cough Drops | MENTHOL | BOSTON NUTRACEUTICAL PRODUCTION, S.L | c2340f56-9a8e-4eea-e053-2995a90a78fc | 2024-10-07 | Warnings | M012 |
| Natural Herbal Cough Drops | MENTHOL | BOSTON NUTRACEUTICAL PRODUCTION, S.L | a706ee9c-9ed0-d3f1-e053-2a95a90a26d6 | 2024-10-07 | Warnings | M012 |
| Cough Drops | MENTHOL | Topco Associates LLC | eff0b37b-6c08-b687-e053-2a95a90a11a9 | 2024-10-07 | Warnings | M012 |
| Sugar Free Cough Drops | MENTHOL | Topco Associates LLC | efcf2edd-21a3-45f9-e053-2995a90a3865 | 2024-10-07 | Warnings | M012 |
| Cough Drops | MENTHOL | Topco Associates LLC | eff65505-8846-35c2-e053-2a95a90a6b79 | 2024-10-07 | Warnings | M012 |
| Sugar Free Cough Drops | MENTHOL | Topco Associates LLC | eff0fdfe-695a-4e62-e053-2a95a90ab50f | 2024-10-07 | Warnings | M012 |
| Cough Drops | MENTHOL | Topco Associates LLC | eff1a70f-fa71-52b2-e053-2995a90a038c | 2024-10-07 | Warnings | M012 |
| Honey Lemon Menthol Cough Drops | HONEY LEMON MENTHOL | Topco Associates LLC | f5be283b-524d-26af-e053-2995a90a3972 | 2024-10-07 | Warnings | M012 |
| Cough Drops | MENTHOL | Topco Associates LLC | eff16ba3-7e30-aa93-e053-2995a90a64cb | 2024-10-07 | Warnings | M012 |
| Menthol Cough Drops | MENTHOL | Target Corporation Inc. | ebf6bcf5-9384-052a-e053-2a95a90a30a5 | 2024-10-07 | Warnings | M012 |
| Rompe Pecho SF Flu SF Flu | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | Efficient Laboratories Inc | 06eac696-e8f6-ac50-e063-6394a90a2ed6 | 2024-10-07 | Warnings | M012 |
| dg health nasal four | PHENYLEPHRINE HYDROCHLORIDE | Dolgencorp, LLC | ceeeb016-8e46-40b8-9923-8a4270475f45 | 2024-10-04 | Warnings | M012 |
| Topcare Nasal Four | PHENYLEPHRINE HYDROCHLORIDE | Topco Associates LLC | 99bc8829-167b-4cf8-8421-57da369f24cd | 2024-10-04 | Warnings | M012 |
| basic care nasal | PHENYLEPHRINE HYDROCHLORIDE | Amazon.com Services LLC | 858648f6-f454-4008-9ea8-ad060c217833 | 2024-10-04 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995441 | codeine phosphate 7.5 MG / guaiFENesin 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | MAR-COF CG 7.5 MG / 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution [Mar-cof CG] | SBD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution | SCD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 7.5 MG / guaifenesin 225 MG per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | Mar-cof CG (codeine phosphate 7.5MG / guaifenesin 225 MG) per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0682-0475-16 | 00682047516 | 473 mL in 1 BOTTLE (0682-0475-16) | 473 ml | 2008-12-01 | 0000-00-00 | No | No | Current |